FLACS vs Phaco in Shallow Anterior Chamber

July 3, 2018 updated by: Abhay R. Vasavada, Iladevi Cataract and IOL Research Center

Intraoperative Performance and Postoperative Outcomes Following Femtosecond Laser Assisted Cataract Surgery (FLACS) and Manual Phacoemulsification in Eyes With Shallow Anterior Chamber

Phacoemulsification in eyes with a shallow anterior chamber (ACD < 2.2mm) presents with problems of safe access to the cataract and increased vulnerability of the endothelium and a higher tendency of complications such as descemet's detachment and iris prolapse. A shallow anterior chamber is also responsible for the high incidence of glaucoma and postoperative complications after cataract surgery. Femtosecond assisted cataract surgery has made cataract surgery safer and more predictable. The effective phacoemulsification time and intra-operative manipulation is greatly reduced in FLACS. However phacoemulsification still remains the most widely performed cataract surgery around the world. Post-operative outcomes after phacoemulsification in patients having shallow anterior chamber have been extensively reported in literature over the years.

There is no head to head comparison in terms of intraoperative performance and post-operative outcomes between FLACS and phacoemulsification in eyes with shallow anterior chamber.

The aim is to compare the intra-operative performance and post-operative outcomes in eyes undergoing femtosecond laser assisted cataract surgery versus eyes undergoing phacoemulsification in eyes having shallow anterior chamber.

The study will bring an understanding on the question: Do patients undergoing Femtosecond laser assisted cataract surgery behave differently from those undergoing phacoemulsification?

Study Overview

Detailed Description

Inclusion Criteria:

  • Age-related cataract
  • Shallow Anterior Chamber (<2.5mm)

Exclusion Criteria:

-Ocular co-morbidity - corneal disorders, glaucoma, uveitis, previous ocular surgery

Surgical Technique :

  • Standardized, Single Surgeon
  • 2.2 mm clear corneal temporal incision
  • FLACS Group : Capsulorhexis, Lens Fragmentation with femto laser

The investigators will be evaluating the following parameters:

  1. Primary outcome measure Corneal thickness on day 1, week 1 and 1 month (Change in corneal thickness of 15% from preop. will be considered significant).
  2. Secondary outcome measures

    • Corneal clarity -on day 1, week 1 and 1 month postoperatively
    • Anterior chamber cells and flare (Hogan's criteria)
    • Percentage change in endothelial cell density from preoperatively to 3 months postoperatively
    • Unaided visual acuity (distance) on day 1 and 1 month.
    • Best corrected distance visual acuity 1 month postoperatively
  3. Other Observations :

1) Cumulative Dissipated Energy (CDE) 2) Surgical time 3) Fluid used 4) Descemets membrane detachment during surgery 5) Incidence of iris trauma 6) Any other intra-operative complications

Study Type

Interventional

Enrollment (Actual)

91

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Gujarat
      • Ahmedabad, Gujarat, India, 380052
        • Iladevi Cataract & IOL Research Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

30 years to 100 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • uncomplicated, age related cataracts
  • Shallow anterior chamber (measured as </=2.5mm )

Exclusion Criteria:

  • Coexisting ocular morbidity,
  • inability to come for followup

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Phacoemulsification Cataract Surgery
Procedure / Surgery : Phacoemulsification Surgery
Phacoemulsification in eyes with shallow anterior chamber (<2.5mm depth)
Active Comparator: Femtosecond Cataract Surgery
Procedure / SUrgery - Femtosecond Laser Cataract surgery
Femtosecond Cataract Surgery in eyes with shallow anterior chamber < 2.5mm

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Central Corneal Thickness
Time Frame: Postoperative Day 1
Central Corneal Thickness
Postoperative Day 1

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Anterior Chamber Inflammation
Time Frame: Postoperative Day 1
Anterior chamber cells and flare (Hogan's criteria)
Postoperative Day 1
Endothelial Cell Morphology
Time Frame: Postoperative 6 months
Endothelial Cell Density
Postoperative 6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Abhay Vasavada, MS,FRCS, Iladevi Cataract & IOL Research Centre, Ahmedabad

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2017

Primary Completion (Actual)

December 1, 2017

Study Completion (Actual)

January 15, 2018

Study Registration Dates

First Submitted

June 11, 2018

First Submitted That Met QC Criteria

July 3, 2018

First Posted (Actual)

July 16, 2018

Study Record Updates

Last Update Posted (Actual)

July 16, 2018

Last Update Submitted That Met QC Criteria

July 3, 2018

Last Verified

July 1, 2018

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • FLACS1

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cataract Surgery

Clinical Trials on Phacoemulsification Cataract SUrgery

3
Subscribe